What Are the Clinical Implications of Mutation Burden?
The clinical implications of mutation burden are significant. A high TMB can serve as a predictive marker for the effectiveness of immunotherapy. For instance, patients with high TMB are more likely to respond to checkpoint inhibitors like pembrolizumab and nivolumab. Additionally, TMB can also serve as a prognostic marker, indicating the likely course or outcome of the disease.
